Clinical evaluation of BioFire® multiplex-PCR panel for acute undifferentiated febrile illnesses in travellers: a prospective multicentre study
Journal of Travel Medicine · 2023
DOI: 10.1093/jtm/taad041 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Travel Medicine, 2023. Verfasst von Daniel Camprubí-Ferrer und 24 weiteren Autor:innen. Beteiligte Einrichtung: ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Chikungunya Fever, Malaria, Rickettsia, Dengue. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: BioFire Diagnostics, Research Award Grant from the International Society of Travel Medicine.
Abstract (Originalsprache)
Background
Identifying the causes of Acute Undifferentiated Febrile Illness (AUFI) is key to improve the management of returning travellers with fever. We evaluated a BioFire®FilmArray® prototype panel of multiplex nucleic acid amplification tests (NAAT) targeting different relevant pathogens in travellers returning with fever.
Methods
Prospective, multicentre study to evaluate a prototype panel in whole blood samples of adult international travellers presenting with AUFI in three European travel Clinics/Hospitals (November 2017–November 2019). We evaluated 15 target analytes: Plasmodium spp., Plasmodium falciparum, Plasmodium knowlesi, Plasmodium malariae, Plasmodium ovale, Plasmodium vivax, chikungunya virus, dengue virus, Zika virus, Anaplasma phagocytophilum, Borrelia spp., Leptospira spp., Orientia tsutsugamushi, Rickettsia spp. and Salmonella spp. Results were compared with composite reference standards (CRSs) for each target infection, including direct methods [smear microscopy, rapid diagnostic test (RDT), reference NAAT and blood cultures] and indirect methods (paired serology).
Findings
Among 455 travellers with AUFI, 229 target infections were diagnosed; the prototype panel detected 143 (overall sensitivity and specificity of 62.5 and 99.8%, respectively). The panel identified all Plasmodium infections (n = 82). Sensitivity for dengue (n = 71) was 92.9, 80.8 and 68.5% compared with RDT, NAAT and CRS, respectively. Compared with direct methods and CRS, respectively, the prototype panel detected 4/4 and 4/6 chikungunya, 2/2 and 4/29 Leptospira spp., 1/1 and 1/6 O. tsutsugamushi and 2/2 and 2/55 Rickettsia spp., but 0/2 and 0/10 Zika, 0/1 and 0/11 A. phagocytophylum and 0/3 Borrelia spp. diagnosed by serology and only 1/7 Salmonella spp. diagnosed by blood cultures. 77/86 (89.5%) infections not detected by the panel were diagnosed by serology.
Interpretation
The prototype panel allowed rapid and reliable diagnosis for malaria, dengue and chikungunya. Further improvements are needed to improve its sensitivity for Zika and important travel-related bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
- Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.
- Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
- Microbiology Department, Hospital Clínic Barcelona, Barcelona, Spain.
- bioMérieux, Centre Christophe Mérieux, Parc PolyTec, Grenoble, France.
- BioFire Diagnostics, LLC, bioMérieux Company, Salt Lake City, UT, USA.
Förderung
- BioFire Diagnostics
- Research Award Grant from the International Society of Travel Medicine
Zitieren
APA
Camprubí-Ferrer, D., Cobuccio, L., Van Den Broucke, S., Balerdi-Sarasola, L., Genton, B., Bottieau, E., Navero-Castillejos, J., Martinez, M. J., Jay, C., Grange, A., Borland, S., Vaughn, M., Rodriguez-Valero, N., Almuedo-Riera, A., D'Acremont, V., Subirà, C., de Alba, T., Cruz, A., Van Esbroeck, M., …, & Muñoz, J. (2023). Clinical evaluation of BioFire® multiplex-PCR panel for acute undifferentiated febrile illnesses in travellers: a prospective multicentre study. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taad041
Vancouver
Camprubí-Ferrer D, Cobuccio L, Van Den Broucke S, Balerdi-Sarasola L, Genton B, Bottieau E, et al. Clinical evaluation of BioFire® multiplex-PCR panel for acute undifferentiated febrile illnesses in travellers: a prospective multicentre study. Journal of Travel Medicine. 2023. doi:10.1093/jtm/taad041
BibTeX
@article{CamprubFerrer2023,
author = {Camprubí-Ferrer, Daniel and Cobuccio, Ludovico and Van Den Broucke, Steven and Balerdi-Sarasola, Leire and Genton, Blaise and Bottieau, Emmanuel and Navero-Castillejos, Jessica and Martinez, Miguel J and Jay, Corinne and Grange, Anne and Borland, Stéphanie and Vaughn, Mike and Rodriguez-Valero, Natalia and Almuedo-Riera, Alex and D'Acremont, Valérie and Subirà, Carme and de Alba, Tessa and Cruz, Angeline and Van Esbroeck, Marjan and Smith, Crystal and Hillman, Ashley and Hanberg, Brandon and Trauscht, Rob and Spampanato, Nerissa and Muñoz, Jose},
title = {Clinical evaluation of BioFire® multiplex-PCR panel for acute undifferentiated febrile illnesses in travellers: a prospective multicentre study},
journal = {Journal of Travel Medicine},
year = {2023},
doi = {10.1093/jtm/taad041}
}
EUVIMED